Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hooiveld-Noeken JS"'
Autor:
Visconti A; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Rossi N; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Deriš H; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Lee KA; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Hanić M; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Trbojević-Akmačić I; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Thomas AM; CIBIO, University of Trento, Trento, Italy., Bolte LA; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands., Björk JR; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands., Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Board R; Department of Oncology, Lancashire Teaching Hospitals NHS Trust, Chorley, UK., Harland M; Division of Haematology and Immunology, Institute of Medical Research at St. James', University of Leeds, Leeds, UK., Newton-Bishop J; Division of Haematology and Immunology, Institute of Medical Research at St. James', University of Leeds, Leeds, UK., Harries M; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Sacco JJ; Liverpool Clatterbridge Cancer Centre, Liverpool, UK.; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Lorigan P; The Christie NHS Foundation Trust, Manchester, UK., Shaw HM; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Weersma RK; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands., Spector TD; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK., Nathan P; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Sasieni P; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Bataille V; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK. bataille@doctors.org.uk.; Department of Dermatology, Mount Vernon Cancer Centre, Northwood, UK. bataille@doctors.org.uk.; Department of Dermatology, West Herts NHS Trust, Herts, UK. bataille@doctors.org.uk., Lauc G; Genos Glycoscience Research Laboratory, Zagreb, Croatia.; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia., Falchi M; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK. mario.falchi@kcl.ac.uk.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Feb 18; Vol. 23 (1), pp. 166. Date of Electronic Publication: 2023 Feb 18.
Autor:
Kist de Ruijter L; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van de Donk PP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Giesen D; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Lub-de Hooge MN; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Timens W; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Brouwers AH; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kwee TC; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fine BM; Genentech Inc., South San Francisco, CA, USA., Sanabria Bohórquez SM; Genentech Inc., South San Francisco, CA, USA., Yadav M; Genentech Inc., South San Francisco, CA, USA., Koeppen H; Genentech Inc., South San Francisco, CA, USA., Jing J; Genentech Inc., South San Francisco, CA, USA., Guelman S; Genentech Inc., South San Francisco, CA, USA., Lin MT; Genentech Inc., South San Francisco, CA, USA., Mamounas MJ; Genentech Inc., South San Francisco, CA, USA., Eastham JR; Genentech Inc., South San Francisco, CA, USA., Kimes PK; Genentech Inc., South San Francisco, CA, USA., Williams SP; Genentech Inc., South San Francisco, CA, USA., Ungewickell A; Genentech Inc., South San Francisco, CA, USA., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. e.g.e.de.vries@umcg.nl.
Publikováno v:
Nature medicine [Nat Med] 2022 Dec; Vol. 28 (12), pp. 2601-2610. Date of Electronic Publication: 2022 Dec 05.
Autor:
Hooiveld-Noeken JS; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Eggen AC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Rácz E; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Jalving M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.jalving@umcg.nl.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Dec; Vol. 180, pp. 103855. Date of Electronic Publication: 2022 Oct 17.
Autor:
van de Donk PP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands., Wind TT; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands., Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands., van der Veen EL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University Medical Center Groningen, Groningen, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands., de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University Medical Center Groningen, Groningen, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. g.a.p.hospers@umcg.nl.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Dec; Vol. 48 (13), pp. 4369-4376. Date of Electronic Publication: 2021 Jun 02.
Autor:
Kist de Ruijter L; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Giesen D; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Brouwers AH; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Nguyen MTL; CytomX Therapeutics Inc., South San Francisco, California., Lu H; CytomX Therapeutics Inc., South San Francisco, California., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Vasiljeva O; CytomX Therapeutics Inc., South San Francisco, California., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Oct 01; Vol. 27 (19), pp. 5325-5333.
Autor:
Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Centre Groningen, the Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Centre Groningen, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, the Netherlands.
Publikováno v:
Immuno-oncology technology [Immunooncol Technol] 2019 Nov 27; Vol. 4, pp. 1-7. Date of Electronic Publication: 2019 Nov 27 (Print Publication: 2019).